Jiangxi Zhenshiming Pharmaceutical Co., Ltd. announced that it has received A+ round of funding on April 16, 2024. The transaction included participation from new and returning investors Zhejiang CONBA Pharmaceutical Co.,Ltd., Fuzhou Digital Economy Investment Group Co., Ltd. and Gold Stone Investment Co., Ltd.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.024 HKD | -4.00% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 6.65M | |
+3.26% | 95.3B | |
+13.75% | 69.05B | |
+20.25% | 63.76B | |
+12.28% | 43.7B | |
+14.14% | 43.06B | |
+17.76% | 34.41B | |
+3.63% | 24.92B | |
-1.14% | 23.07B | |
+6.72% | 19.68B |
- Stock Market
- Equities
- 901 Stock
- News Goldstone Investment Group Limited
- Jiangxi Zhenshiming Pharmaceutical Co., Ltd. announced that it has received funding from Zhejiang CONBA Pharmaceutical Co.,Ltd., Goldstone Investment Group Limited